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Summary
The mechanisms by which molecular chaperones as-
sist quality control of cytosolic proteins are poorly
understood. Analysis of the chaperone requirements
for degradation of misfolded variants of a cytosolic
protein, the VHL tumor suppressor, reveals that dis-
tinct chaperone pathways mediate its folding and
quality control. While both folding and degradation of
VHL require Hsp70, the chaperonin TRiC is essential
for folding but is dispensable for degradation. Con-
versely, the chaperone Hsp90 neither participates in
VHL folding nor is required to maintain misfolded
VHL solubility but is essential for its degradation. The
cochaperone HOP/Sti1p also participates in VHL qual-
ity control and may direct the triage decision by
bridging the Hsp70-Hsp90 interaction. Our finding
that a distinct chaperone complex is uniquely re-
quired for quality control provides evidence for active
and specific chaperone participation in triage deci-
sions and suggests that a hierarchy of chaperone in-
teractions can control the alternate fates of a cyto-
solic protein.
Introduction
Efficient clearance of nonnative polypeptides is essen-
tial for cell survival. Failure to eliminate misfolded pro-
teins can result in toxic aggregates associated with
conformational diseases such as Parkinson’s and Hunt-
ington’s (Horwich and Weissman, 1997; Dobson, 1999).
In bacteria, ATP-dependent AAA proteases degrade
misfolded proteins, while eukaryotes primarily utilize
the ubiquitin-proteasome pathway to fulfill this role
(Dougan et al., 2002; Goldberg, 2003). The mechanisms
that enforce quality control of cytosolic proteins and
the components that target a nonnative polypeptide for
elimination remain ill defined despite their critical im-
portance for cell viability.
Molecular chaperones, which bind nonnative poly-
peptides and promote their folding to the native state
(Bukau and Horwich, 1998; Frydman, 2001; Hartl and
Hayer-Hartl, 2002), are thought to aid in the destruction
of misfolded proteins. For example, quality control in
the secretory pathway, known as ERAD (endoplasmic
reticulum-associated degradation), requires the partici-
pation of ER chaperones and the cytosolic AAA-ATPase
Cdc48p (Fewell et al., 2001; Hampton, 2002; Kostova
and Wolf, 2003). Likewise, chaperones participate in
the degradation of folding-defective cytosolic proteins*Correspondence: jfrydman@stanford.eduinE. coli and mitochondria (Dougan et al., 2002; Kandror et
al., 1994; Kaser and Langer, 2000). In eukaryotes, in vitro
experiments demonstrate a requirement for Hsp70 in
the degradation of some misfolded proteins (Bercovich
et al., 1997), while in vivo experiments in yeast implicate
the Hsp70 cofactor Ydj1p in this process (Lee et al.,
1996). However, these studies do not clarify the ques-
tion of how chaperones contribute to the triage deci-
sion that targets polypeptides for degradation. Under-
standing how chaperones help select nonnative proteins
for degradation has been hindered by the use of grossly
misfolded or “abnormal” polypeptides as models. Given
that these proteins cannot fold under any circumstance
and can only either be degraded or aggregate, they are
not adequate to address the mechanism of a physio-
logical triage decision. Based on these studies, a sim-
ple model for protein quality control was proposed,
whereby chaperones perform a passive “holding” func-
tion, maintaining the solubility of misfolded intermedi-
ates, thus facilitating sampling by the ubiquitination
machinery (Wickner et al., 1999). In this view, the role
of chaperones in quality control is an extension of their
primary role in folding, in which repeated attempts to
fold a defective protein, through cycles of chaperone
binding and release to the bulk solution, would eventu-
ally result in passive partitioning to the degradation ma-
chinery (Wickner et al., 1999). A distinguishing feature
of this model is that the requirement for chaperones in
quality control stems primarily from the need to main-
tain the solubility of misfolded intermediates and is
thus nonspecific. Consequently, any chaperone system
capable of binding a nonnative polypeptide may assist
its degradation. An alternative model, raised by recent
observations that some chaperones specifically in-
teract with components of the ubiquitin-proteasome
pathway (Verma et al., 2000; Cyr et al., 2002), envisions
that certain cellular chaperones play an active and spe-
cific role in selecting a polypeptide for cytosolic quality
control (McClellan and Frydman, 2001). Accordingly, in-
activation of these particular chaperones should com-
promise the degradation of misfolded proteins.
Here we sought to distinguish between a passive,
nonspecific model of chaperone action and an active
and specific role for chaperones in cytosolic quality
control. To this end, we studied the chaperone require-
ments for the degradation of a physiologically relevant
substrate of the quality-control machinery. Unlike pre-
viously studied model substrates for cytosolic quality
control, the chaperone-mediated folding pathway of
the von Hippel-Lindau (VHL) tumor-suppressor protein
is well characterized (Feldman et al., 1999; Feldman et
al., 2003; Hansen et al., 2002; Melville et al., 2003), af-
fording us the opportunity to compare the chaperone
requirements for folding and degradation. Studies in
yeast and mammalian cells indicate that both Hsp70
and the chaperonin TRiC are required for correct fold-
ing of newly translated VHL, which is coupled to as-
sembly of a ternary complex with its partner proteins
elongin B and C (VHL-elongin BC, herein VBC complex;
Feldman et al., 1999; Feldman et al., 2003; Hansen et
Cell
740al., 2002; Melville et al., 2003). These chaperones ap-
pear to function sequentially in the VHL folding path-
way, with loss of Hsp70 function blocking association
with TRiC and loss of TRiC function having no effect on
Hsp70 association (Feldman et al., 2003; Melville et al.,
2003). Importantly, loss of VHL function is associated
with a number of inherited and spontaneous tumors
(Kaelin, 2002), and several tumor-causing mutations are
known to disrupt elongin BC binding and abrogate VHL
folding (e.g., Feldman et al., 1999), leading to VHL deg-
radation by the proteasome (Schoenfeld et al., 2000).
In this study we establish that the chaperone sys-
tems required for VHL degradation are different from
those required for its folding. While the chaperonin
TRiC/CCT is required for VHL folding, it is dispensable
for degradation. In contrast, Hsp90 is not required for
VHL folding but is specifically essential for its degrada-
tion. Our findings are inconsistent with proposed mod-
els for cytosolic quality control whereby the same
chaperones that promote folding of a polypeptide will
also facilitate its passive partitioning to the degradation
machinery. Because VHL is still soluble and associated
with chaperones, including Hsp70 and TRiC, in Hsp90-
deficient cells where degradation is prevented, it ap-
pears that the role of chaperones in quality control is
not limited to passively maintaining solubility of mis-
folded intermediates. Instead, it appears that only
some cellular chaperones can target misfolded VHL for
degradation, supporting the idea that specific, rather
than stochastic, chaperone pathways act in folding and
degradation. The identification of two distinct path-
ways of chaperone interactions for VHL, one leading to
folding and one to degradation, indicates that the fate
of a cytosolic protein may be controlled by a hierarchy
of chaperone interactions. These findings provide novel
insights into the logic underlying triage decisions in the
eukaryotic cytosol.
Results
Misfolded VHL Is Degraded
by the Ubiquitin-Proteasome Pathway
VHL folding is coupled to its assembly into a ternary
complex with its partner proteins elongin B and C. In
mammalian cells, tumor-causing mutations in VHL that
disrupt elongin BC binding, such as L158P, abrogate
VHL folding (Feldman et al., 1999) leading to its degra-
dation by the proteasome (Schoenfeld et al., 2000; see
also Figure S1). To establish whether VHL quality con-
trol proceeds similarly in yeast, folding-defective mu-
tant L158P VHL was expressed in Saccharomyces
cerevisiae under the control of a galactose-regulated
promoter. Glucose addition repressed expression, al-
lowing us to follow the fate of misfolded VHL. L158P
VHL was degraded with a half-life of w40 min (Figure
1A, L158P, left; see also Figure S6B). As described (Mel-
ville et al., 2003; Schoenfeld et al., 2000), wild-type (wt)
VHL expressed in the absence of elongin BC also fails
to fold and is degraded, with a comparable, albeit
slightly longer, half-life (w100 min; Figure 1A, VHL, left;
see also Figure S6A). In principle, the observed differ-
ence in half-life of L158P and wt VHL could arise from
partial stabilization of wt VHL by the yeast elongin C
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iigure 1. VHL Is Degraded by the Ubiquitin-Proteasome Pathway
A) VHL/L158P expression in wild-type (wt CIM3) or proteasome
utant (cim3-1) yeast was repressed by the addition of glucose,
nd samples were collected at the indicated chase times. Data are
resented as anti-VHL immunoblots of the resulting cell extracts.
B) VHL degradation was examined in wt ELC1 and Delc1 strains
s described above.
C) Immunoblot analysis of VHL/L158P degradation rates in wt
east, isogenic strains lacking UBC4 and UBC5, and yeast deleted
or UBC4, UBC5, UBC6, and UBC7.omolog Elc1p, which can bind in vitro to VHL-derived
eptides (Botuyan et al., 1999). This is not the case,
owever, as deletion of ELC1 did not alter the rate of
t VHL degradation (Delc1; Figure 1B). The difference
n half-life may instead arise from conformational differ-
nces between these misfolded VHL variants.
We next examined the role of the ubiquitin-protea-
ome pathway in VHL degradation. Both misfolded VHL
ariants were stabilized in the proteasome mutant
trains cim3-1 and pre1-1 (Figure 1A, right-hand panels
nd data not shown). Furthermore, VHL was also stabi-
ized by the deletion of specific ubiquitin-conjugating
nzymes (UBCs or E2s, Figure 1C), indicating that VHL
egradation is ubiquitin dependent. While L158P VHL
as strongly stabilized in cells lacking the functionally
edundant UBC4 and UBC5 E2s (Figure 1C), full stabili-
ation of wt VHL required the additional deletion of the
2 pair UBC6/UBC7 (Figure 1C). This discrepancy fur-
her suggests that conformational differences between
hese VHL variants may influence their ubiquitination
athway. Interestingly, UBC4/UBC5 and UBC6/UBC7
ere previously implicated in the degradation of other
isfolded proteins (Hampton, 2002; Seufert and Jentsch,
990). Altogether, these data establish that in yeast, as
n mammalian cells (Schoenfeld et al., 2000), misfolded
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741VHL degradation proceeds via the ubiquitin-protea-
some system.
Degradation of Misfolded VHL Requires Specific
Molecular Chaperones
Correct VHL folding in both mammalian and yeast cells
is mediated by a chaperone pathway consisting of
Hsp70 and the chaperonin TRiC/CCT (Figure 2A; Feld-
man et al., 1999; Feldman et al., 2003; Melville et al.,
2003). We therefore next examined whether these
chaperones, required for VHL folding, also participate
in the elimination of both misfolded variants: tumor mu-
tant L158P and wt VHL expressed in the absence of
elongin BC. The role of TRiC in VHL degradation wasFigure 2. Role of TRiC/CCT and Hsp70 in VHL Degradation
(A) Scheme: chaperone-mediated folding of VHL requires both
Hsp70 and TRiC.
(B) The steady-state degradation of VHL was assessed at 30°C and
37°C in wt yeast or yeast with a temperature-sensitive mutation
(tcp1-2; cct4-1) in the TRiC subunits TCP1 and CCT4.
(C) VHL/L158P degradation was examined in cells harboring dele-
tions of SSA2-4 and containing either wt SSA1or a temperature-
sensitive allele, ssa1-45, at both 30°C and 37°C.examined in two chaperonin-defective strains harbor-
ing temperature-sensitive alleles in TRiC subunits 1
(tcp1-2; Ursic et al., 1994) and 4 (cct4-1/anc2-1; Vinh
and Drubin, 1994). Incubation at the nonpermissive
temperature, which abolishes VHL folding (Melville et
al., 2003), did not prevent VHL degradation in either
strain (37°C; Figure 2B; see also Figure S6Ai). Thus,
TRiC function, while required for VHL folding, is dis-
pensable for the degradation of misfolded VHL.
Next, the role of Hsp70 was assessed using the ssa1-
45 temperature-sensitive strain and the isogenic strain
containing wt SSA1 (Becker et al., 1996; Melville et al.,
2003). Whereas VHL degradation in SSA1 cells was un-
affected by the shift from 30°C to 37°C (Figure 2C, top
panel), L158P and wt VHL were strongly stabilized in
ssa1-45 cells at the nonpermissive temperature (37°C;
Figure 2C; see also Figures S6Aii and S5Bi). Impor-
tantly, the ubiquitin-proteasome system is fully func-
tional in the absence of SSA function, as the incubation
of ssa1-45 cells at the nonpermissive temperature does
not compromise the proteasome-dependent degrada-
tion of other substrates (Brodsky et al., 1999; Nishikawa
et al., 2001; Taxis et al., 2003). Notably, a second class
of cytosolic Hsp70s, Ssb1p and Ssb2p, are dispensable
for VHL degradation (data not shown), suggesting a
specific requirement for the Hsp70 Ssa1p in both VHL
folding (Melville et al., 2003) and degradation (Figure 2C).
The Hsp70 Cochaperone STI1 Is Required
for Degradation of Misfolded VHL
To better define the role of Hsp70 in misfolded VHL
degradation, we next examined the requirement for
several cofactors known to modulate the activity of
Ssa1p (Frydman, 2001). The Hsp40 homolog Ydj1p,
previously reported to contribute to the degradation of
misfolded canavanyl polypeptides in yeast (Lee et al.,
1996), is not required for VHL degradation (Figure 3A,
top panel). Additionally, no defect in VHL degradation
was observed in a strain with a temperature-sensitive
allele of the essential Hsp40 homolog SIS1 (data not
shown), suggesting that VHL degradation may instead
depend on another of the w13 cytosolic Hsp40 homo-
logs (Walsh et al., 2004).
One notable difference between the SSA and SSB
Hsp70 classes is that SSAs contain a C-terminal motif,
EEVD, which mediates interaction with tetratricopep-
tide (TPR) domain-containing proteins (Scheufler et al.,
2000). Strikingly, the degradation of both misfolded VHL
variants was markedly inhibited in cells lacking the
TPR-containing Ssap cofactor STI1 (Figure 3A, bottom
panel; Figure S6Aiv).
Successful partitioning to the ubiquitination and deg-
radation machinery requires that the polypeptide re-
main soluble. We therefore examined whether deletion
of STI1 blocks degradation by failing to prevent aggre-
gation of misfolded VHL. In wt cells, most of the VHL
protein was soluble and remained in the supernatant
(Sn) of a high-speed centrifugation, with only a small
fraction found in the insoluble pellet (Pel; Figure 3B).
Importantly, no change in the solubility of VHL was ob-
served in cells lacking Sti1p (Figure 3B). Because VHL
remains soluble in the absence of Sti1p yet fails to be
degraded, we conclude that the function of Sti1p in
Cell
742Figure 3. The Ssa1p Cochaperone Sti1p Is Required for VHL Degra-
dation
(A) VHL/L158P degradation was examined in cells lacking the
Hsp70 cofactors YDJ1 and STI1.
(B) VHL solubility was assessed in wt and Dsti1 yeast by comparing
equivalent amounts of total (T), supernatant (Sn), and pellet (Pel)
fractions (see Experimental Procedures) by SDS-PAGE and anti-
VHL immunoblot.
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This result suggests an active role for this cochaperone
in VHL quality control.
Hsp90 Is Specifically Required for VHL Degradation
but Is Dispensable for Folding
STI1, also called HOP (for Hsp70-Hsp90-organizing
protein), has the unique ability to bridge a complex be-
tween Hsp70 and Hsp90 via specific interactions with
its TPR domains (Scheufler et al., 2000). Thus, the
requirement for Sti1p in VHL degradation may reflect a
role not only for Hsp70 in this process but also for
Hsp90. We therefore examined the contribution of
Hsp90 to VHL degradation. Both L158P and wt VHL ex-
hibited impaired degradation in cells carrying a temper-
ature-sensitive allele of HSP82 (hsp82ts G170D; Nathan
and Lindquist, 1995) at the nonpermissive temperature
both under steady-state conditions (Figure 4A; see also
Figures S5Aiii and S5Bii) and in pulse-chase analyses
(Figure S2). Inefficient VHL degradation was also ob-
served at 30°C in strains harboring constitutively de-
fective point mutants of Hsp90, such as T101I and
G313S (Nathan and Lindquist, 1995; Figure S3). Fur-
thermore, Hsp90 inhibition with the ansamycin macbe-
cin II also results in VHL stabilization, confirming a
requirement for Hsp90 in VHL degradation (data not
shown; see also Figure 4D below). Importantly, the
ubiquitin-proteasome pathway was fully functional un-
der our experimental conditions, as hsp82 G170D cells
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cupported the proteasome-dependent degradation of
everal substrates of this pathway at the nonpermissive
emperature (Figure S4; for similar results, see also
axis et al., 2003). For instance, the proteasome sub-
trate firefly luciferase was efficiently degraded in
sp82 G170D cells at 37°C (Figure S4). Furthermore,
egradation of two misfolded TRiC/CCT interacting
roteins, the folding-defective actin mutant E364K
Drummond et al., 1991) and nonnative CDC55, was un-
ffected when Hsp90 function was compromised (Fig-
re S4). We conclude that the stabilization of VHL in
sp82 G170D cells is not due to a general defect in
roteasome-mediated degradation. Intriguingly, degra-
ation of nonnative Tub3p, also a chaperonin substrate,
as partially compromised in hsp82 G170D cells at
7°C, suggesting that Hsp90 may play a role in quality
ontrol of other nonnative proteins (see also Discussion
nd Figure S7).
The requirement for Hsp90 in VHL degradation may
n principle reflect a previously undescribed role for
sp90 in VHL folding, which is coupled to assembly of
he VBC complex (Feldman et al., 2003; Feldman et al.,
999; Melville et al., 2003). To test this possibility, we
xpressed VHL at the nonpermissive temperature in
sp82 G170D cells already containing elongin BC and
ssessed its folding by several established assays (Fig-
re 4B; Feldman et al., 2003; Feldman et al., 1999; Mel-
ille et al., 2003). Correctly folded VHL in VBC is re-
istant to mild protease digestion. Accordingly, VHL
xpressed in the absence of elongin BC is sensitive to
rotease treatment (Figure 4Ba, top panel). In contrast,
HL expressed in the presence of elongin BC was re-
istant to protease digestion in both wild-type and
sp90-deficient cells (Figure 4Ba, center and bottom
anels). The formation of correctly folded VBC was also
onitored by coimmunoprecipitation of VHL with elon-
in BC (Figure 4Bb) and nondenaturing gel electropho-
esis (Figure S5; Melville et al., 2003). Consistent with
ur protease-sensitivity data, both assays indicated
hat VBC assembly was not affected in hsp82 G170D
ells expressing VHL at either the permissive or non-
ermissive temperature (Figure 4Bb, compare last two
anes). Importantly, as expected from these results, loss
f Hsp90 function did not affect the solubility of VHL or
ts association with both Hsp70 and TRiC (data not
hown).
Our findings that Hsp90 is dispensable for VHL fold-
ng, but required for VHL degradation, were confirmed
y analysis of these processes in mammalian cells (Fig-
res 4C and 4D). VBC assembly was analyzed in HEK
ells as previously described (Feldman et al., 2003;
eldman et al., 1999; Melville et al., 2003), by coex-
ressing Flag-tagged wild-type VHL and elongin BC
ollowed by VHL immunoprecipitation under stringent
onditions (Figure 4C). The formation of tightly folded
BC was unaffected by incubation with the Hsp90-
nhibiting drug geldanamycin (Figure 4C; Young et al.,
001). In contrast, geldanamycin treatment strongly in-
ibited the degradation of L158P VHL in a concentra-
ion-dependent manner (Figure 4D). Taken together,
hese experiments demonstrate that while VHL folding
s independent of Hsp90, VHL degradation requires
sp90 function. We conclude that Hsp90 plays a spe-
ific role in misfolded VHL degradation, raising the pos-
Role of Chaperones in Protein Quality Control
743Figure 4. Hsp90 Is Specifically Required for VHL Degradation, but Not for VHL Folding, in Yeast and Mammalian Cells
(A) VHL/L158P degradation was examined in wt HSP82 and temperature-sensitive hsp82 (G170D) cells at both 30°C and 37°C.
(B) Scheme: experimental outline for assessing VHL folding in wt HSP82 and temperature-sensitive hsp82 cells. VHL expression was induced
at either 30°C or 37°C in hsp82 (G170D) cells already containing myc-tagged elongin BC. Formation of a correctly folded VBC complex was
assessed using (Ba) a protease-protection assay (shown only for 37°C) and (Bb) an elongin BC affinity pull-down assay followed by the
detection of VHL by immunoblot. VHL expressed in the absence of elongin BC is misfolded and serves as a negative control in both assays.
(C) The Hsp90 inhibitor geldanamycin (GA) does not affect VBC assembly in mammalian cells. HEK293 cells coexpressing Flag-tagged wild-
type VHL and elongin BC or containing the backbone vector plasmid (vector) were incubated with or without 5 M GA prior to [35S]methionine
labeling and immunoprecipitation with anti-Flag antibodies.
(D) The Hsp90 inhibitor GA inhibits degradation of misfolded VHL in mammalian cells. HEK293 cells expressing L158P VHL were chased with
cycloheximide in the absence (lanes 2 and 6) or presence of increasing concentrations of GA (lanes 3–5 and 7–9). At the indicated chase
times, L158P VHL and tubulin (which serves as a loading control) were detected by immunoblot analysis.sibility that an Hsp70-Sti1p-Hsp90 complex functions
in cytosolic quality control.
A Specific Hsp90-Containing Complex Mediates
Degradation of Misfolded VHL
We next determined whether misfolded VHL interacts
with Hsp70 and Hsp90 in vivo. Immunoblot analysis of
VHL immunoprecipitations confirmed its association
with the Hsp70 Ssa1p (Figure 5A; Melville et al., 2003)
and established its association with Hsp90 (Figure 5A).
Analysis of VHL bound proteins by mass spectrometry
confirmed these results (data not shown) and also re-
vealed an association with the Hsp110 chaperone
Sse1p, which is genetically and biochemically linked to
Hsp90 and STI1 (Goeckeler et al., 2002; Liu et al., 1999).
Immunoblot analysis confirmed this interaction (Figure
5A), indicating that additional Hsp90 cofactors might
have a role in the degradation of misfolded VHL. Of note,
no VHL interaction was observed for Ydj1p, which isnot involved in VHL folding or degradation, nor with ac-
tin, which served as a specificity control (Figure 5A).
Hsp90 is the central component of a dynamic chap-
erone machine whose best-characterized role is in the
maturation of a subset of substrates, also called “cli-
ent” proteins, including kinases and steroid hormone
receptors (Picard, 2002; Young et al., 2001). It is pro-
posed that these folding clients proceed from “early”
Hsp90 complexes containing Hsp70, Sti1p/HOP, Sse1p,
and Hsp90 to “late” or “mature” complexes containing
Hsp90 and a different complement of cochaperones,
among them peptidyl-prolyl isomerases and Sba1p/p23
(Figure 5B; Picard, 2002; Young et al., 2001). Impor-
tantly, formation of the late complex(es) is essential for
folding of client substrate proteins. We next examined
the role of these Hsp90 complexes in VHL degradation.
As observed for STI1, deletion of SSE1 resulted in
strong stabilization of misfolded VHL (Figure 5B, Early
Complex), consistent with our finding that Sse1p asso-
Cell
744Figure 5. An “Early” Hsp90 Complex Partici-
pates in VHL Degradation
(A) Immunoprecipitation of VHL was followed
by detection of associated Ssa1/2p, Hsp90,
Sse1p, and Ydj1p with the appropriate anti-
sera. Actin serves as a specificity control for
the immunoprecipitation.
(B) Scheme: sequential formation of Hsp90
complexes in client-protein folding. The con-
tribution of Hsp90 subcomplexes to VHL
degradation was examined in yeast lacking
SSE1 (an early complex component) or
SBA1 (a late complex component) and in the
isogenic wt strains.ciates with VHL. In contrast, SBA1 deletion had no ef-
fect on VHL degradation (Figure 5B, Late Complex).
Thus, while components of the early Hsp90 complex,
including STI1, SSE1, and Hsp70, are required for VHL
degradation, components of the late complex, such as
Sba1p/p23 and Aha1p (data not shown), are dispens-
able, suggesting that quality control of misfolded VHL
is specifically dependent on an early Hsp90 complex
(Figure 6).
Discussion
A major unexplored question in cell biology is how the
cell selects misfolded cytosolic proteins and targets
them for elimination. Triage decisions must balance the
need to protect nonnative newly translated proteins
that have not yet reached their fully folded state with
the requirement to prevent the accumulation of aggre-
gation-prone toxic species. Here we investigated how
the cellular chaperone machinery participates in quality
control of a physiologically relevant misfolded cytosolic
protein. The availability of folding-defective variants of
a cellular protein with a well-characterized chaperone-
dependent folding pathway, the VHL tumor suppressor,
allowed us to distinguish between possible models for
chaperone function in quality control. Previous studies
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dsing artificial or damaged substrates that were either
rossly misfolded and aggregation prone or poorly
haracterized with regard to their chaperone interac-
ions led to a model whereby chaperones play a passive,
onspecific holding function in degradation, merely
aintaining nonnative polypeptides in a soluble state.
more complex role for chaperones in cytosolic quality
ontrol emerges from our in vivo analysis of misfolded
HL degradation, which indicates that specific, rather
han stochastic, chaperone pathways govern its folding
nd degradation (Figure 6). Of the two chaperones re-
uired for VHL folding, TRiC/CCT and Hsp70 (Ssa1p),
nly Ssa1p is required for degradation, while TRiC/
CT function is dispensable (Figure 2). Strikingly, VHL
egradation specifically requires another chaperone,
sp90, which does not participate in VHL folding (Fig-
re 4). Importantly, VHL stabilization in Hsp90- or Sti1-
eficient cells is not caused by aggregation (Figure 3B
nd data not shown) but rather results from the loss of
pecific chaperone interactions with Hsp90 and a sub-
et of Hsp90 cofactors. Since VHL is still soluble and
ssociated with chaperones, including Hsp70 and
RiC, in Dsti1 or Hsp90-deficient cells where degrada-
ion is prevented, we conclude that binding to TRiC or
sp70 does not suffice to target misfolded VHL for
egradation. Furthermore, because loss of Hsp90 func-
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745tion blocks VHL degradation, our data indicate that
Hsp90 is not merely engaging VHL in a futile folding
cycle but is actually actively required for degradation.
These findings are inconsistent with proposed models
for cytosolic quality control whereby chaperones func-
tion only to maintain polypeptide solubility and pas-
sively facilitate partitioning to the degradation ma-
chinery. Instead, it appears that certain chaperones
play an active and specific role in the triage process.
The specific requirement for Hsp90 in the degrada-
tion of a protein that is not one of its folding clients is
surprising. Our data suggest that early Hsp90 com-
plexes not only are intermediates leading to formation
of late Hsp90 complexes during client-protein folding
but may also have an independent function in quality
control. Accordingly, we propose that Hsp90 function
is not limited to folding a restricted subset of client pro-
teins (Young et al., 2001) but may also function in qual-
ity control of nonclient, cytosolic proteins. How may
Hsp90 mediate protein quality control? A number of
mechanisms are consistent with our findings. For in-
stance, Hsp90 may directly recruit specific ubiquitina-
tion components, as observed in mammalian cells for
the ubiquitin ligase CHIP, which interacts with both
Hsp90 and Hsp70 (Ballinger et al., 1999; Connell et al.,
2001). Although no CHIP homologs exist in yeast and
the role of CHIP in misfolded-protein degradation is not
yet well established, it is possible that additional ubiq-
uitin ligases interact with an early Hsp90 complex (see
for instance Bansal et al., 2004). Alternatively, a Hsp90
complex may facilitate direct delivery of the substrate
to the proteasome since Hsp90 has been shown to in-
teract with proteasome complexes (Verma et al., 2000).
Finally, it is also possible that Hsp90 action is uniquely
required to generate a specific conformation of the mis-
folded substrate that can be subsequently recognized
by a ubiquitin ligase involved in quality control. Future
studies should clarify the precise mechanism by which
Hsp90 promotes VHL quality control.Figure 6. Two Distinct Chaperone Pathways Mediate VHL Folding
and VHL Quality Control
Newly synthesized VHL is folded with the assistance of Hsp70 and
TRiC. Folding-defective VHL is transferred to an early Hsp90 com-
plex with the assistance of Sti1p. An Hsp90 subcomplex containing
Hsp70 (Ssa1p), Sti1p, Sse1p, and Hsp90 facilitates the recognition
and degradation of VHL by the ubiquitin-proteasome pathway.The idea that Hsp90 and some of its cofactors have
an additional function in quality control of misfolded
proteins is consistent with the strong upregulation of
the Hsp90 system by amino acid analogs that generate
misfolded proteins or during environmental stress (Ni-
colet and Craig, 1989), with the colocalization of Hsp90
with misfolded protein aggregates (Dou et al., 2003;
Mitsui et al., 2002) and with the observation that Hsp90
enhances the proteasome-mediated antigen process-
ing of ovalbumin (Yamano et al., 2002). Interestingly,
while inhibition of Hsp90 by ansamycins, which abo-
lishes folding of client proteins, leads to degradation of
the Hsp90 bound client (Young et al., 2001), we find that
inhibition of Hsp90 with ansamycins blocks the degra-
dation of VHL (Figure 4D). Although the substrate
spectrum of most cellular chaperones, including Hsp90,
remains ill defined even for folding substrates, it is likely
that our findings for VHL also apply to the quality con-
trol of other cellular proteins. For instance, the protea-
some-mediated degradation of both CYP2E1 (cyto-
chrome P450 2E1) and apolipoprotein B is also blocked
upon treatment with Hsp90-inhibiting ansamycin drugs
(Goasduff and Cederbaum, 2000; Gusarova et al., 2001).
Impairing Hsp90 function enhances ApoB maturation
(Gusarova et al., 2001), suggesting that, similar to VHL,
Hsp90 is also required for ApoB degradation but dis-
pensable for folding. On the other hand, the degrada-
tion of nonnative variants of actin and CDC55 is not com-
promised in the absence of Hsp90 function (Figure S4),
indicating the existence of alternative pathways of cyto-
solic quality control. Preliminary experiments compar-
ing wild-type and hsp82 cells in pulse-chase analyses
to determine what percentage of rapidly turned-over
amino acid analog-containing proteins are stabilized by
Hsp90 deficiency demonstrated anw20% reduction of
total degradation when Hsp90 function was compro-
mised (Figure S7). Since the pulse-chase experiment
looks at the degradation of all rapidly turned-over poly-
peptides, whether or not they are found in the ER, mito-
chondria, or the cytoplasm, the fraction of cytosolic
proteins stabilized in the Hsp90 mutants may be higher
than this rough analysis indicates. Thus, Hsp90 is im-
portant for the degradation of a significant fraction of,
but not all, misfolded polypeptides. It is likely that cells
contain several chaperone pathways leading to the
degradation of distinct classes of misfolded proteins,
similar to what is observed for chaperone-mediated
protein folding, where different chaperone pathways
mediate the folding of different classes of proteins. This
might be expected, given the critical importance of en-
suring efficient protein quality control for cell viability
and the fact that, upon misfolding, different structural
classes of proteins may require distinct cellular compo-
nents for efficient recognition and elimination. An impor-
tant question for future studies will be to define the
spectrum of proteins that require Hsp90 for quality control.
Our analysis of the chaperone pathways required for
folding and quality control of the VHL tumor suppressor
provides novel insights into the logic underlying triage
decisions in the eukaryotic cytosol. The identification
of two distinct pathways of chaperone interactions for
VHL (Figure 6), one leading to folding and one to degra-
dation, suggests that the fate of a given cytosolic pro-
tein may be controlled by a hierarchy of chaperone in-
Cell
746teractions. In the case of VHL, cotranslational coupling
mechanisms may establish an initial association with
TRiC (Thulasiraman et al., 1999), resulting in a chaper-
one hierarchy that favors folding over degradation.
However, failure to fold may allow subsequent associa-
tion with the Hsp90 complex, leading to degradation.
Consistent with this model, we find that the tcp1-2 mu-
tation, which destabilizes the TRiC complex, resulting
in substrate binding defects (Camasses et al., 2003),
slightly enhances the degradation rate of VHL (Figure
2B), suggesting that the folding and degradation path-
ways may be in a dynamic equilibrium. In principle, the
fate of newly translated VHL may be governed by the
affinity and binding kinetics of its folding intermediates
to the chaperone systems in each pathway. Of note,
Hsp90 has been proposed to recognize structured fold-
ing intermediates (Picard, 2002; Young et al., 2001),
such as those that might result from failed folding
attempts. Accordingly, Hsp90 may recognize a confor-
mation of VHL that is not reached under productive
folding conditions; that might be why, in the presence
of elongin BC, TRiC-mediated folding has precedence
over Hsp90 binding and degradation. Hsp70, uniquely
required for both folding and degradation, may play a
key role in the decision-making process, possibly in co-
operation with the Hsp70-Hsp90-bridging cochaperone
Sti1p/HOP. Strikingly, similar principles may be at work
during quality control of glycosylated proteins in the ER
(Ellgaard and Helenius, 2003), where association with
the chaperone calnexin is conducive to folding, while
transfer to EDEM signals the commitment to degrada-
tion. Our findings for VHL may reflect a more general
principle of protein triage and provide a conceptual
framework to understand how the cell determines that
a nonnative polypeptide is a “lost cause.”
Experimental Procedures
Yeast Media, Plasmids, and Strains
Yeast media preparation, growth, transformations, and manipula-
tions were performed according to standard protocols (Adams et
al., 1997).
His6-VHL and His6-L158P were cloned into pESC (GAL1 URA3;
Stratagene, La Jolla, California). The pESC plasmid expressing
elongin B and elongin C is described elsewhere (Melville et al.,
2003).
The yeast strains used in this study are as follows: wt CIM3
(YPG499; MATa ura3-52 leu2-D1 his3-D200 trp1-D63 lys2-801
ade2-101) and cim3-1 (CMY762; ura3-52 leu2-D1 his3-D200
cim3-1) (Ghislain et al., 1993); MHY501 (MATα his3-D200 leu2-3,
112 ura3-52 lys2-801 trp1-1) and the isogenic mutant strains
MHY508 (ubc4::HIS3 ubc5::LEU2) and MHY570 (ubc4::TRP1
ubc5::LEU2 ubc6::HIS3 ubc7::LEU2) (Chen et al., 1993); wt TCP1
(DUY558; MATα leu2-3, 112 ura3-52 trp1-7 tcp1::LEU2 p-TCP1
[TRP1]) and tcp1-2 (DUY326; MATα leu2-3, 112 ura3-52 trp1-7
tcp1::LEU2 p-tcp1-2 [TRP1]) (Ursic et al., 1994); SSA1 (JN516;
MATα ura3-52 leu2-3 his3-11, 15 trp1-D1 lys2 SSA1 ssa2::LEU2
ssa3::TRP1 ssa4::LYS2) and ssa1-45 (JB67; MATα ura3-52 leu2-3
his3-11, 15 trp1-D1 lys2 ssa1::ssa1-45 ssa2::LEU2 ssa3::TRP1
ssa4::LYS2) (Becker et al., 1996); wt Dsti1, Dydj1, and Dsse1 (MATa/
MATα orfD::kanMX4/orfD::kanMX4 ura3D0/ura3D0 leu2D0/leu2D0
his3D1/his3D1 met15D0/MET15 lys2D0/LYS2 (Saccharomyces Ge-
nome Project; Winzeler et al., 1999); wt HSP82 (iP82a; MATa
ura3-1 leu2-3,12 his3-11,15 trp1-1 can1-100 ade2-1 hsc82::LEU2
hsp82::LEU2 his3-11, 15::GPD-HSP82-HIS3) and hsp82G170D
(iG170Da; MATa ura3-1 leu2-3,12 his3-11,15 trp1-1 can1-100
ade2-1 hsc82::LEU2 hsp82::LEU2 his3-11, 15::GPD-hsp82G170D-
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(IS3) (also iG313Sa, same genotype; Nathan and Lindquist, 1995);
t SBA1 (YNK100; MATα pdr5-101 ura3) and Dsba1 (YNK233;
ATa pdr5-101 ura3 sba1::HIS3) (Bohen, 1998); W303 (MATa
ra3-1 leu2-3, 112 his3-11, 15 trp1-1 ade2-1) and W303 Delc1
MATa ura3-1 leu2-3, 112 his3-11, 15 trp1-1 ade2-1 elc1::KANr)
Jackson et al., 2000).
ell Culture and Transfection
EK293 cells cultured in DMEM/5% FCS (Gibco) were transfected
ith 8–10 g of plasmid DNA using calcium phosphate as de-
cribed (Feldman et al., 2003).
Mammalian expression plasmids for wt VHL, L158P VHL, elongin
, and elongin C were described previously (Feldman et al., 2003).
dditional Reagents
he Hsp90-inhibiting ansamycins macbecin II and geldanamycin
GA) were obtained from the NCI Drug Synthesis and Chemistry
ranch and were solubilized in DMSO (Sigma) prior to use.
HL Degradation
teady-State Degradation Assay in Yeast
HL expression was induced by galactose addition to cells at a
ery low density. Next the cells were grown at 30°C for w16 hr to
n OD600 of 0.5–0.8, diluted to an OD600 of 0.2 in 50 ml of YPD to
epress VHL expression (time 0), and further incubated at 30°C or
7°C. Samples were removed at indicated time points, harvested,
ashed once with sterile double-distilled H2O, and frozen in liquid
itrogen. Cell pellets were stored at −20°C until extract preparation.
xtracts were prepared by 10 min agitation with glass beads on a
urbo-mix vortex (Fisher Scientific, Pittsburgh) in lysis buffer (50
M Tris [pH 7.4], 1 mM EDTA, 0.5% SDS, 1 mM dithiothreitol [DTT],
mM phenylmethyl-sulfonyl fluoride [PMSF], and 1 g/ml pep-
tatin-A), heated at 65°C for 10 min, and spun at 16,000 × g for 10
in at 4°C. Protein concentrations were determined with the BCA
rotein assay kit (Pierce, Rockford, Illinois). Samples from each
ime point containing identical amounts of protein (15 g for wt
HL and 45 g for L158P VHL) were separated on 12% SDS-PAGE
els and transferred to Protran nitrocellulose (0.45 M pore size;
chleicher & Schuell Inc., Keene, New Hampshire). VHL was de-
ected using anti-VHL primary antibody as described (Melville et
l., 2003). As a loading control, actin was detected using anti-actin
rimary antibody (for example, see Figure S3; Melville et al., 2003).
ctin, luciferase, GST-CDC55, and TUB3-myc steady-state degra-
ation assays were conducted exactly as described for the VHL
teady-state degradation assay, with the exception that the appro-
riate time courses and antisera for detection were used.
teady-State Degradation Assay in Mammalian Cells
he effect of GA on the degradation of L158P VHL was determined
sing a cycloheximide chase. Cells were incubated with 1 mM
ycloheximide together with increasing concentrations of GA or an
quivalent volume of DMSO. At the indicated time points, cells
ere lysed in buffer M (25 mM Tris-HCl [pH 7.4], 5 mM EDTA, 100
M NaCl, 1 mM DTT, 0.1 mM PMSF, 10% glycerol, 1% Triton X-100,
mM NaN3, 2 mM deoxyglucose) and clarified by centrifugation at
0,000 × g for 20 min. Fifty micrograms of each resulting cell ex-
ract was analyzed by SDS-PAGE and immunoblot. VHL was de-
ected using anti-VHL primary antibody; as a loading control, tu-
ulin was visualized using a monoclonal anti-β-tubulin antibody
Amersham Pharmacia Biotech, Piscataway, New Jersey).
etabolic Labeling and Pulse-Chase Experiments
sp82 (G170D) yeast expressing VHL were grown in SC Gal media
o midlogarithmic phase. Cells were harvested, washed twice with
Met Gal media, then resuspended to 5 ODs/ml in −Met Gal. The
ells were then incubated at 30°C or 37°C with gentle shaking
w200 rpm) for 30 min. 0.3 mCi of [35S]methionine/cysteine was
dded, and cells were labeled for 5 min. Cells were collected,
ashed, and resuspended in YPD supplemented with 0.5 mg/ml
ycloheximide and 0.5 mg/ml methionine. Four hundred microliters
f cells was removed to 400 l ice-cold 0.1 M NaN3 at the indicated
imes. Yeast cell pellets were lysed as described above, and 75 g
f each time point was immunoprecipitated with anti-VHL antisera
or control mouse IgG) and protein G-Sepharose. Following SDS-
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747PAGE, the gels were dried and exposed to a phosphorimager cas-
sette for 3 days.
For experiments in Figure 4C and Figure S1, cells were labeled
for 12 hr in MEM containing 0.2 mCi [35S]methionine/cysteine mix
(NEN) and 1% FCS. Where indicated, cells were chased into media
containing DMEM/5% FCS and 0.5 mg/ml cycloheximide then
lysed as above. Cell extracts (50 g) were analyzed using a strin-
gent immunoprecipitation protocol as described (Feldman et al.,
2003). Equivalent amounts of nonimmune antibodies were used in
control immunoprecipitations.
VHL Solubility Assay
Cells expressing VHL were grown at 30°C or 37°C (for temperature-
sensitive strains; other strains were grown only at 30°C), harvested,
washed once with sterile double-distilled H2O, and resuspended in
500 l of native yeast lysis buffer (20 mM HEPES [pH 7.4], 200 mM
NaCl, 10% glycerol, 1 mM DTT, 1 mM PMSF, and 1 g/ml pepsta-
tin-A). Lysates were prepared by bead beating (10 min at 4°C) and
clarified by centrifugation at 16,000 × g for 10 min at 4°C. One
hundred and fifty microliters of this supernatant was set aside as
total protein. One hundred and fifty microliters was spun in a Beck-
man T120.1 rotor at 350,000 × g for 15 min at 4°C. This supernatant
was removed and designated the soluble fraction. The pellet was
resolubilized by heating in 200 l 1× SDS sample buffer. Fifty micro-
liters of 4× SDS sample buffer was added to the total-protein and
soluble-fraction samples. Equal amounts of each fraction were re-
solved by SDS-PAGE followed by immunoblot analysis with anti-
VHL antisera.
VHL Folding Assays
Yeast containing a single wild-type allele of Hsp90 (wt 90) or a tem-
perature-sensitive point mutant allele (G170D) were transformed
with pCu426-His6-VHL (URA3) and pESC-myc-elongin B/myc-elon-
gin C (TRP1). To induce expression of elongin BC, cells were grown
overnight in SC Gal Raf (lacking uracil and tryptophan). Cultures
were split, placed at 30°C and 37°C, and allowed to equilibrate for
1 hr. Then, VHL was induced for 2 hr by addition of 300 M CuSO4.
Cells were harvested, washed once with sterile double-distilled
H2O, resuspended in VBC lysis buffer (25 mM Tris [pH 8.0], 75 mM
ammonium sulfate, 2.5 mM EDTA, 2.5% glycerol, 1 mM DTT, 1 mM
PMSF, and 1 g/ml pepstatin-A) and lysed as above. Lysates were
clarified by centrifugation at 16,000 × g for 30 min at 4°C, and pro-
tein concentration was determined by the BCA method.
VHL folding was examined as described (Melville et al., 2003;
Feldman et al., 2003). To examine VBC assembly, 250 g of each
lysate was immunoprecipitated with 2 l of anti-myc antibody (Co-
vance Inc., Princeton, New Jersey) and 40 l of protein G slurry
(Amersham Pharmacia Biotech). The protein G beads were washed
three times with wash buffer (50 mM Tris [pH 8.0], 250 mM NaCl,
10% glycerol, 0.5% Triton X-100). Immunoprecipitated proteins
were analyzed by SDS-PAGE (15%), anti-VHL immunoblot to detect
VHL, and anti-myc immunoblot to detect elongin BC. To examine
the thermolysin sensitivity of VHL, lysates were buffer exchanged
into thermolysin buffer (50 mM Tris [pH 8.0], 10 mM CaCl2, 50 mM
KCl, and 5% glycerol) using NAP 5 columns (Amersham Pharmacia
Biotech). Reactions containing 120 g lysate and 0.3 mg/ml
thermolysin in a total volume of 180 l were incubated on ice for
the indicated times and analyzed by SDS-PAGE followed by immu-
noblotting with anti-VHL antisera.
Supplemental Data
Supplemental Data include seven figures and are available with this
article online at http://www.cell.com/cgi/content/full/121/5/739/
DC1/.
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